253 related articles for article (PubMed ID: 31534175)
21. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.
Herbst A; Jurinovic V; Krebs S; Thieme SE; Blum H; Göke B; Kolligs FT
BMC Genomics; 2014 Jan; 15():74. PubMed ID: 24467841
[TBL] [Abstract][Full Text] [Related]
23. CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
Park S; Lee MS; Gwak J; Choi TI; Lee Y; Ju BG; Kim CH; Oh S
Cell Death Dis; 2018 Oct; 9(10):1023. PubMed ID: 30283086
[TBL] [Abstract][Full Text] [Related]
24. A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):252-259. PubMed ID: 30825095
[TBL] [Abstract][Full Text] [Related]
25. Wnt stabilization of β-catenin reveals principles for morphogen receptor-scaffold assemblies.
Kim SE; Huang H; Zhao M; Zhang X; Zhang A; Semonov MV; MacDonald BT; Zhang X; Garcia Abreu J; Peng L; He X
Science; 2013 May; 340(6134):867-70. PubMed ID: 23579495
[TBL] [Abstract][Full Text] [Related]
26. Wnt/β-catenin signaling regulates ependymal cell development and adult homeostasis.
Xing L; Anbarchian T; Tsai JM; Plant GW; Nusse R
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5954-E5962. PubMed ID: 29891676
[TBL] [Abstract][Full Text] [Related]
27. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
28. Nuclear AXIN2 represses MYC gene expression.
Rennoll SA; Konsavage WM; Yochum GS
Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
[TBL] [Abstract][Full Text] [Related]
29. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
[TBL] [Abstract][Full Text] [Related]
30. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
31. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer.
Cha PH; Choi KY
BMB Rep; 2016 Sep; 49(9):455-6. PubMed ID: 27470214
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
[TBL] [Abstract][Full Text] [Related]
34. Amer2 protein is a novel negative regulator of Wnt/β-catenin signaling involved in neuroectodermal patterning.
Pfister AS; Tanneberger K; Schambony A; Behrens J
J Biol Chem; 2012 Jan; 287(3):1734-41. PubMed ID: 22128170
[TBL] [Abstract][Full Text] [Related]
35. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
Xu MX; Zhao L; Deng C; Yang L; Wang Y; Guo T; Li L; Lin J; Zhang L
Int J Oncol; 2013 Dec; 43(6):1951-9. PubMed ID: 24064724
[TBL] [Abstract][Full Text] [Related]
36. Assessing the clinical utility of Wnt pathway markers in colorectal cancer.
Veloudis G; Pappas A; Gourgiotis S; Falidas E; Dimitriou N; Karavokiros I; Aggelou A; Komborozos V; Petraki C; Menounos P; Bramis I; Bastounis E; Pikoulis E
J BUON; 2017; 22(2):431-436. PubMed ID: 28534366
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1).
Tanneberger K; Pfister AS; Kriz V; Bryja V; Schambony A; Behrens J
J Biol Chem; 2011 Jun; 286(22):19204-14. PubMed ID: 21498506
[TBL] [Abstract][Full Text] [Related]
38. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
Shi X; Zhao Y; Fan C
J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
[TBL] [Abstract][Full Text] [Related]
39. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
40. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
